Acquisition by Pratt Raymond Dennis of 150000 shares of Savara subject to Rule 16b-3
SVRA Stock | USD 3.36 0.20 5.62% |
About 61% of Savara's investor base is looking to short. The analysis of the overall investor sentiment regarding Savara Inc suggests that many traders are alarmed. The current market sentiment, together with Savara's historical and current headlines, can help investors time the market. In addition, many technical investors use Savara Inc stock news signals to limit their universe of possible portfolio assets.
Savara |
Filed transaction by Savara Inc officer. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Read at macroaxis.com
Savara Fundamental Analysis
We analyze Savara's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Savara using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Savara based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash And Equivalents
Cash And Equivalents Comparative Analysis
Savara is currently under evaluation in cash and equivalents category among its peers. Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Savara Inc Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Savara stock to make a market-neutral strategy. Peer analysis of Savara could also be used in its relative valuation, which is a method of valuing Savara by comparing valuation metrics with similar companies.
Peers
Savara Related Equities
PTIX | Protagenic Therapeutics | 5.77 | ||||
ACLX | Arcellx | 5.73 | ||||
IKNA | Ikena Oncology | 1.80 | ||||
FENC | Fennec Pharmaceuticals | 1.32 | ||||
EWTX | Edgewise Therapeutics | 1.15 | ||||
CRNX | Crinetics Pharmaceuticals | 0.97 | ||||
XOMAO | XOMA | 0.40 | ||||
XOMA | XOMA Corp | 0.47 | ||||
KZR | Kezar Life | 0.86 | ||||
AVTE | Aerovate Therapeutics | 1.14 | ||||
GPCR | Structure Therapeutics | 1.30 | ||||
RZLT | Rezolute | 1.39 | ||||
RVMD | Revolution Medicines | 1.82 | ||||
STOK | Stoke Therapeutics | 2.11 | ||||
XLO | Xilio Development | 2.80 | ||||
TRDA | Entrada Therapeutics | 2.97 | ||||
DYN | Dyne Therapeutics | 3.04 | ||||
ALXO | Alx Oncology | 4.43 | ||||
TPST | Tempest Therapeutics | 4.49 | ||||
SRRK | Scholar Rock | 5.26 | ||||
TARA | Protara Therapeutics | 6.30 | ||||
ANAB | AnaptysBio | 32.83 |
Complementary Tools for Savara Stock analysis
When running Savara's price analysis, check to measure Savara's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Savara is operating at the current time. Most of Savara's value examination focuses on studying past and present price action to predict the probability of Savara's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Savara's price. Additionally, you may evaluate how the addition of Savara to your portfolios can decrease your overall portfolio volatility.
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
CEOs Directory Screen CEOs from public companies around the world | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |